Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 15 de 15
Filtrar
1.
Internist (Berl) ; 63(3): 321-324, 2022 Mar.
Artículo en Alemán | MEDLINE | ID: mdl-34825918

RESUMEN

A 67-year-old woman presented to the emergency department due to acute dyspnea. Computed tomography of the chest showed a pronounced bilateral pulmonary artery embolism. Echocardiography demonstrated a large floating thrombus in the right atrium and right ventricle, which extended through a persistent foramen ovale via the left atrium into the left ventricle. A thrombectomy was later successfully performed.


Asunto(s)
Foramen Oval Permeable , Foramen Oval , Embolia Pulmonar , Trombosis , Anciano , Femenino , Foramen Oval Permeable/diagnóstico , Foramen Oval Permeable/diagnóstico por imagen , Humanos , Arteria Pulmonar/diagnóstico por imagen , Arteria Pulmonar/cirugía , Embolia Pulmonar/diagnóstico , Embolia Pulmonar/etiología , Trombosis/diagnóstico , Trombosis/cirugía
2.
Internist (Berl) ; 62(2): 203-206, 2021 Feb.
Artículo en Alemán | MEDLINE | ID: mdl-33052456

RESUMEN

Tuberculosis (TB) is one of the most common infectious diseases worldwide. The case of a 20-year old male refugee from Somalia, who initially presented with right-sided upper abdominal pain, vomiting, weight loss and jaundice with suspected cholecystitis is reported. In the course of further diagnostics, pyloric stenosis surprisingly appeared, which, like the cholestasis, was caused by compressing peripancreatic lymph nodes. Lymph node cytology finally showed evidence of caseating necrosis with evidence of TB pathogens.


Asunto(s)
Dolor Abdominal/etiología , Tuberculosis/diagnóstico , Vómitos/etiología , Dolor Abdominal/diagnóstico , Colecistitis/diagnóstico , Humanos , Ictericia/diagnóstico , Masculino , Refugiados , Somalia , Pérdida de Peso , Adulto Joven
3.
Cancer Biomark ; 27(1): 129-137, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-31771043

RESUMEN

OBJECTIVE: The EDIM (Epitope detection in monocytes) blood test is based on two biomarkers Apo10 and TKTL1. Apo10 is responsible for cell proliferation and resistance to apoptosis. TKTL1 plays a major role in anaerobic glycolysis of tumor cells, leading to destruction of the basal membrane and metastasis as well as in controlling cell cycle. For the first time we analyzed Apo10 and TKLT1 in patients with cholangiocellular (CCC), pancreatic (PC), and colorectal carcinoma (CRC). METHODS: Blood samples of 62 patients with CCC, PC, and CRC were measured and compared to 29 control patients. We also investigated 13 patients with inflammatory conditions, because elevated TKTL1 and Apo10 have been previously described in affected individuals. Flow cytometry was used to detect surface antigens CD14+/CD16+ (activated monocytes/macrophages). Percentages of macrophages harboring TKTL1 and Apo10 were determined. A combined EDIM score (EDIM-CS: TKTL1 plus Apo10) was calculated. Results were correlated with serum tumor markers CEA and CA19-9. RESULTS: Patients with CCC had 100% positive EDIM-CS but CEA and CA19-9 were positive in only 22.2% and 70%, respectively. Patients with PC had 100% positive EDIM-CS but positive tumor markers in only 37.5% (CEA) and 72.7% (CA19-9). Patients with CRC had 100% positive EDIM-CS but only 50% positive CEA. EDIM-CS was positive in 100% (62/62) of all cancer patients and in 0% of healthy individuals. Of the individuals with inflammation, 7.7% had a positive EDIM-CS. CONCLUSION: The sensitivity of the EDIM blood test and the comparison with traditional tumor markers indicate that this new test might improve the detection of carcinomas (CCC, PC and, CRC) and might be relevant for the diagnosis of all tumor entities.


Asunto(s)
Biomarcadores de Tumor/sangre , Colangiocarcinoma/sangre , Neoplasias Colorrectales/sangre , Péptidos y Proteínas de Señalización Intracelular/metabolismo , Neoplasias Pancreáticas/sangre , Transcetolasa/sangre , Anciano , Biomarcadores de Tumor/inmunología , Antígeno CA-19-9/sangre , Antígeno Carcinoembrionario/sangre , Colangiocarcinoma/patología , Neoplasias Colorrectales/patología , Epítopos/sangre , Epítopos/inmunología , Femenino , Citometría de Flujo , Humanos , Macrófagos/inmunología , Masculino , Persona de Mediana Edad , Monocitos/inmunología , Neoplasias Pancreáticas/patología , Transcetolasa/inmunología , Neoplasias Pancreáticas
4.
Z Gastroenterol ; 54(10): 1147-1150, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27723906

RESUMEN

AFP-producing adenocarcinoma of the esophagus and esophagogastric junction are rare tumor diseases. These tumors show an aggressive behavior characterized by early occurrence of liver metastases and mimic hepatocellular carcinoma (HCC). A general recommendation for palliative therapy is not established for these special tumors.Here we report about a 61-year-old man with multiple liver metastases and high serum alpha-fetoprotein (AFP) level. First, HCC was suspected, but further evaluation showed an AFP-producing adenocarcinoma of the esophagogastric junction with unusual findings on further immunohistochemical analysis. Palliative chemotherapy with FLOT (5-fluorouracil, leucovorin, oxaliplatin, and docetaxel) regime showed a 9 month duration of partial response.


Asunto(s)
Adenocarcinoma/tratamiento farmacológico , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Neoplasias Esofágicas/tratamiento farmacológico , Neoplasias Esofágicas/patología , Unión Esofagogástrica/patología , Cuidados Paliativos/métodos , Adenocarcinoma/metabolismo , Adenocarcinoma/patología , Docetaxel , Neoplasias Esofágicas/metabolismo , Fluorouracilo/administración & dosificación , Humanos , Leucovorina/administración & dosificación , Masculino , Persona de Mediana Edad , Compuestos Organoplatinos/administración & dosificación , Oxaliplatino , Taxoides/administración & dosificación , Resultado del Tratamiento , alfa-Fetoproteínas/metabolismo
5.
Z Gastroenterol ; 53(9): 1087-90, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26367025

RESUMEN

Recurrent Pyogenic Cholangitis (RPC) or Primary Hepatolithiasis is a common disease of the biliary tract in Asia, whereas it is usually not seen in Europeans. With increasing global mobility, the disease will be encountered in Europe more frequently, too. It should therefore be considered as a differential diagnosis in patients from endemic countries with recurrent symptoms of cholestasis/cholangitis and bile duct dilations, strictures and hepatolithiasis. In this case report, we present the history of a 37-year old patient from Sri Lanka and describe typical aspects of RPC. The patient presented at our hospital with scleral jaundice and pruritus. In the past she had been treated for septic cholangitis. Diagnosis in our patient was made after laboratory tests, MRT/MRCP and ERC. She was treated interventionally by ERC and is now monitored on a regular basis.


Asunto(s)
Enfermedades de las Vías Biliares/diagnóstico , Colangitis/diagnóstico , Coledocolitiasis/diagnóstico , Errores Diagnósticos/prevención & control , Adulto , Diagnóstico Diferencial , Femenino , Humanos , Recurrencia
6.
Z Gastroenterol ; 53(3): 205-7, 2015 Mar.
Artículo en Alemán | MEDLINE | ID: mdl-25775170

RESUMEN

The over the scope clip (OTSC) is mainly used for closure of gastrointestinal endoluminal defects and treatment of gastrointestinal bleeding. Its use for resection of subepithelial tumors or full-thickness resection is still under investigation. Duodenal neuroendocrine tumors (NET) are rare neoplasms. Endoscopic resection is appropriate up to a size of 20  mm, however positive deep margins are a frequent challenge in these subepithelial tumors. We report on a 60-year-old male patient who had undergone endoscopic mucosal resection with R1 deep margins of a NET (G1) in the duodenal bulb. To avoid local surgical resection in this multimorbid patient, we performed OTSC-assisted deep resection. Complete resection (R0) was achieved, and no complications occurred. Our report suggests that OTSC-assisted resection of subepithelial tumors is a possible and safe option, especially for patient's and in locations with a high perioperative risk.


Asunto(s)
Neoplasias Duodenales/patología , Neoplasias Duodenales/cirugía , Endoscopía Gastrointestinal/métodos , Tumores Neuroendocrinos/patología , Tumores Neuroendocrinos/cirugía , Anciano , Humanos , Masculino , Resultado del Tratamiento
8.
Radiologe ; 54(7): 660-3, 2014 Jul.
Artículo en Alemán | MEDLINE | ID: mdl-24981446

RESUMEN

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third most common cause of cancer death worldwide. The incidence continues to rise and only a detailed surveillance of patients with chronic liver disease can allow an early assessment. Diagnosis is made by imaging techniques, such as contrast-enhanced ultrasound (CEUS), computed tomography (CT), magnetic resonance imaging (MRI) and also histopathological examination of biopsy material. The determination of the tumor marker alpha fetoprotein (AFP) is no longer established for early detection but can be used as a supplement in addition in HCC history progressio.


Asunto(s)
Biomarcadores de Tumor/sangre , Carcinoma Hepatocelular/diagnóstico , Diagnóstico por Imagen/normas , Neoplasias Hepáticas/diagnóstico , Guías de Práctica Clínica como Asunto , alfa-Fetoproteínas/análisis , Carcinoma Hepatocelular/sangre , Alemania , Adhesión a Directriz/normas , Humanos , Neoplasias Hepáticas/sangre , Oncología Médica/normas , Radiología/normas
9.
Z Gastroenterol ; 52(2): 200-3, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24526405

RESUMEN

Pancreatic acinar cell carcinoma (ACC) is a rare, aggressive variant of pancreatic ductal adenocarcinoma. Surgery is the only curative treatment option and protocols for palliative chemotherapies in this context are not standardized yet. We reported a 63-year-old white male patient who had painless jaundice, weight loss, elevated bilirubin, and a mass of the pancreatic head as well as liver metastasis. Core biopsy revealed the diagnosis of ACC. Therapy with FOLFIRINOX resulted in a significant decrease of the primary tumor and regressiveness of a liver metastasis after chemotherapy. Our report suggests that pancreatic ACC treated by FOLFIRINOX is well tolerated and might be superior to other single chemotherapies in this rare tumor disease.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Carcinoma de Células Acinares/tratamiento farmacológico , Carcinoma de Células Acinares/patología , Neoplasias Pancreáticas/tratamiento farmacológico , Neoplasias Pancreáticas/patología , Camptotecina/administración & dosificación , Camptotecina/análogos & derivados , Carcinoma de Células Acinares/cirugía , Fluorouracilo/administración & dosificación , Humanos , Irinotecán , Leucovorina/administración & dosificación , Masculino , Persona de Mediana Edad , Compuestos Organoplatinos/administración & dosificación , Oxaliplatino , Neoplasias Pancreáticas/cirugía , Resultado del Tratamiento
10.
Endoscopy ; 44(1): 48-52, 2012 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-22198775

RESUMEN

BACKGROUND AND STUDY AIMS: Immunoglobulin G4 (IgG4)-associated cholangitis (IAC) is difficult to diagnose because on cholangiography the associated biliary tract strictures cannot be differentiated from cholangiocarcinoma or primary sclerosing cholangitis (PSC). Serum IgG4 levels show a low sensitivity and specificity and are unreliable, particularly in patients with related diseases such as PSC. As IAC takes place at the biliary epithelium, we hypothesized that IgG4 measurement in bile may have higher sensitivity compared with serum. METHODS: Bile and serum samples were collected during cholangiography in 67 patients, including 23 patients with PSC, 25 with cholangiocarcinoma, 14 with choledocholithiasis, and five with IAC. IgG4 was measured in both bile and serum. RESULTS: Bile IgG4 levels were markedly elevated in patients with IAC compared with patients with other biliary disorders. Whereas elevated serum IgG4 levels were found both in patients with PSC and IAC, biliary IgG4 levels were only increased in patients with IAC. CONCLUSIONS: The study demonstrates that bile IgG4 measurement is possible and may help to distinguish IAC from other diseases.


Asunto(s)
Neoplasias de los Conductos Biliares/diagnóstico , Conductos Biliares Intrahepáticos , Bilis/química , Colangiocarcinoma/diagnóstico , Colangitis/diagnóstico , Inmunoglobulina G/análisis , Adulto , Anciano , Anciano de 80 o más Años , Área Bajo la Curva , Neoplasias de los Conductos Biliares/inmunología , Colangiocarcinoma/inmunología , Colangitis/inmunología , Colangitis/patología , Colangitis Esclerosante/diagnóstico , Colangitis Esclerosante/inmunología , Coledocolitiasis/diagnóstico , Coledocolitiasis/inmunología , Diagnóstico Diferencial , Femenino , Humanos , Inmunoglobulina G/sangre , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Sensibilidad y Especificidad , Adulto Joven
11.
Minerva Endocrinol ; 35(1): 27-33, 2010 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-20386525

RESUMEN

Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of mortality and morbidity. The 5-year survival rate remains less than 5% and in contrast to other solid tumors, survial has changed only little in the last decade. Overall PDAC treatment shows only limited response to conventional chemotherapeutic agents. Several trials on therapy are ongoing and new targeted agents are in development to improve the treatment outcome of this deadly disease. However, our review presents the current developments of molecular therapies, supports the translational PDAC research and encourage you to take part in further clinical studies.


Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma Ductal Pancreático/tratamiento farmacológico , Neoplasias Pancreáticas/tratamiento farmacológico , Anticuerpos Monoclonales/administración & dosificación , Anticuerpos Monoclonales Humanizados , Axitinib , Bencenosulfonatos/administración & dosificación , Bevacizumab , Capecitabina , Carcinoma Ductal Pancreático/genética , Carcinoma Ductal Pancreático/mortalidad , Carcinoma Ductal Pancreático/patología , Cetuximab , Ensayos Clínicos Fase II como Asunto , Ensayos Clínicos Fase III como Asunto , Desoxicitidina/administración & dosificación , Desoxicitidina/análogos & derivados , Receptores ErbB/antagonistas & inhibidores , Clorhidrato de Erlotinib , Fluorouracilo/administración & dosificación , Fluorouracilo/análogos & derivados , Humanos , Imidazoles/administración & dosificación , Indazoles/administración & dosificación , Invasividad Neoplásica , Niacinamida/análogos & derivados , Neoplasias Pancreáticas/genética , Neoplasias Pancreáticas/mortalidad , Neoplasias Pancreáticas/patología , Compuestos de Fenilurea , Ftalazinas/administración & dosificación , Pronóstico , Piridinas/administración & dosificación , Quinazolinas/administración & dosificación , Ensayos Clínicos Controlados Aleatorios como Asunto , Medición de Riesgo , Sorafenib , Análisis de Supervivencia , Resultado del Tratamiento , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidores , Gemcitabina
13.
Internist (Berl) ; 46(10): 1147-51, 2005 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-15983754

RESUMEN

The side effects caused by malaria prophylaxis with mefloquine (Lariam) are well known. We describe the case of a 42-year-old female Caucasian patient suffering from painless jaundice and showing elevated liver, cholestasis and inflammation laboratory findings 7 days after returning from Tanzania. Acute cholecystitis was diagnosed by ultrasound. Treatment with parenteral nutrition and antibiotic therapy did not show any beneficial effect. Excluding the possibility of infectious diseases, the elevated laboratory and ultrasound findings were normalized after the discontinuation of the malaria prophylaxis.


Asunto(s)
Colecistitis Aguda/inducido químicamente , Colecistitis Aguda/diagnóstico , Ictericia/inducido químicamente , Ictericia/diagnóstico , Mefloquina/efectos adversos , Viaje , Adulto , Colecistitis Aguda/tratamiento farmacológico , Femenino , Humanos , Ictericia/tratamiento farmacológico , Dolor/diagnóstico , Dolor/etiología , Recreación , Tanzanía
14.
Z Gastroenterol ; 42(5): 379-82, 2004 May.
Artículo en Alemán | MEDLINE | ID: mdl-15136937

RESUMEN

Lichen ruber planus is a common skin and mucosal disease, with very rare involvement of the esophagus. We report on a 68-year-old patient suffering from dysphagia, with a reduced general condition and weight loss of 12 kg in the past 6 months due to lichen planus of the esophagus. Treatment by bougienage was very successful. This case report describes a lichen ruber planus of the esophagus without involvement of skin, genital or oral mucosa.


Asunto(s)
Esofagitis/clasificación , Esofagitis/patología , Liquen Plano/clasificación , Liquen Plano/patología , Anciano , Dilatación/métodos , Esofagitis/diagnóstico , Esofagitis/terapia , Enfermedades de los Genitales Masculinos/clasificación , Enfermedades de los Genitales Masculinos/diagnóstico , Enfermedades de los Genitales Masculinos/patología , Enfermedades de los Genitales Masculinos/terapia , Humanos , Liquen Plano/diagnóstico , Liquen Plano/terapia , Liquen Plano Oral/clasificación , Liquen Plano Oral/diagnóstico , Liquen Plano Oral/patología , Liquen Plano Oral/terapia , Masculino , Enfermedades de la Piel/clasificación , Enfermedades de la Piel/diagnóstico , Enfermedades de la Piel/patología , Enfermedades de la Piel/terapia
15.
Gut ; 52(9): 1304-7, 2003 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-12912862

RESUMEN

BACKGROUND: and aims: Chromosomal instability is one of the most consistent markers of sporadic colorectal cancer in humans. There is growing evidence that telomere shortening is one of the mechanisms leading to chromosomal instability and cancer initiation. METHODS: To test this hypothesis, the telomere length of colorectal epithelial cells and cells from connective tissue was determined at the adenoma-carcinoma transition at the cellular level by quantitative fluorescence in situ hybridisation. RESULTS: Our study showed that the telomere fluorescence intensity of epithelial cells was significantly weaker at the earliest morphologically definable stage of carcinoma-high grade dysplasia with minimal invasive growth-compared with the surrounding adenoma. In contrast, cells from connective tissue had a similar telomere signal intensity at the carcinoma stage compared with the adenoma, and in turn cells from connective tissue had overall significantly stronger telomere fluorescence signals compared with epithelial cells. CONCLUSIONS: These results demonstrate that short telomeres of epithelial cells characterise the adenoma-carcinoma transition during human colorectal carcinogenesis, suggesting that carcinomas arise from cells with critical short telomeres within the adenoma. Since the adenoma-carcinoma transition in colorectal cancer is characterised by an increase in chromosomal instability and anaphase bridges, our data support the hypothesis that short telomeres initiate colorectal cancer by induction of chromosomal instability.


Asunto(s)
Adenoma/ultraestructura , Neoplasias Colorrectales/ultraestructura , Telómero/ultraestructura , Adenoma/genética , Anciano , Anciano de 80 o más Años , Biomarcadores de Tumor , Neoplasias Colorrectales/genética , Tejido Conectivo/ultraestructura , Células Epiteliales/ultraestructura , Humanos , Hibridación Fluorescente in Situ , Telómero/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...